Clinical Trial Update: Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial of OLT1177 Gel for knee osteoarthritis has completed; the document summarizes the trial status rather than presenting results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• OLT1177 Gel (dapansutrile)

Snippet

Sponsor: Olatec Therapeutics LLC | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED